ShanghaiTech University Knowledge Management System
Engineering of human mesenchymal stem cells resistant to multiple natural killer subtypes | |
2022 | |
Source Publication | INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
![]() |
ISSN | 1449-2288 |
Volume | 18Issue:1 |
Status | 已发表 |
DOI | 10.7150/ijbs.64640 |
Abstract | Mesenchymal stem cells (MSCs) as a therapeutic promise are often quickly cleared by innate immune cells of the host including natural killer (NK) cells. Efforts have been made to generate immune-escaping human embryonic stem cells (hESCs) where T cell immunity is evaded by defecting beta-2-microglobulin (B2M), a common unit for human leukocyte antigen (HLA) class I, and NK cells are inhibited via ectopic expression of HLA-E or -G. However, NK subtypes vary among recipients and even at different pathologic statuses. It is necessary to dissect and optimize the efficacy of the immune-escaping cells against NK subtypes. Here, we first generated B2M knockout hESCs and differentiated them to MSCs (EMSCs) and found that NK resistance occurred with B2M-/- EMSCs expressing HLA-E and -G only when they were transduced via an inducible lentiviral system in a dose-dependent manner but not when they were inserted into a safe harbor. HLA-E and -G expressed at high levels together in transduced EMSCs inhibited three major NK subtypes, including NKG2A+/LILRB1+, NKG2A+/LILRB1-, and NKG2A-/LILRB1+, which was further potentiated by IFN-gamma priming. Thus, this study engineers MSCs with resistance to multiple NK subtypes and underscores that dosage matters when a transgene is used to confer a novel effect to host cells, especially for therapeutic cells to evade immune rejection. |
Keyword | Human embryonic stem cells mesenchymal stem cells natural killer cells innate immunity immune rejection |
URL | 查看原文 |
Indexed By | SCI ; SCIE |
Language | 英语 |
Funding Project | University of Macau Research Committee funds MYRG["2016-00070-FHS","2017-00124-FHS"] ; Macau Science and Technology Development Fund (FDCT)["095/2017/A1","0112-2018-A3"] ; FDCT-National Natural Science Foundation of China[0008-2019-AFJ] |
WOS Research Area | Biochemistry & Molecular Biology ; Life Sciences & Biomedicine - Other Topics |
WOS Subject | Biochemistry & Molecular Biology ; Biology |
WOS ID | WOS:000741493200004 |
Publisher | IVYSPRING INT PUBL |
Citation statistics | |
Document Type | 期刊论文 |
Identifier | https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/150323 |
Collection | 生命科学与技术学院_PI研究组_林照博组 |
Corresponding Author | Xu, Ren-He |
Affiliation | 1.Univ Macau, Fac Hlth Sci, Ctr Reprod Dev & Aging, Taipa, Macau, Peoples R China 2.Univ Macau, Fac Hlth Sci, Inst Translat Med, Taipa, Macau, Peoples R China 3.Univ Macau, Minist Educ, Frontiers Sci Ctr Precis Oncol, Taipa, Macau, Peoples R China 4.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China 5.Tsinghua Univ, Int Grad Sch Shenzhen, Shenzhen Key Lab Hlth Sci & Technol, Shenzhen, Peoples R China |
Recommended Citation GB/T 7714 | Zheng, Dejin,Wang, Xiaoyan,Zhang, Zhenwu,et al. Engineering of human mesenchymal stem cells resistant to multiple natural killer subtypes[J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES,2022,18(1). |
APA | Zheng, Dejin.,Wang, Xiaoyan.,Zhang, Zhenwu.,Li, Enqin.,Yeung, Cheungkwan.,...&Xu, Ren-He.(2022).Engineering of human mesenchymal stem cells resistant to multiple natural killer subtypes.INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES,18(1). |
MLA | Zheng, Dejin,et al."Engineering of human mesenchymal stem cells resistant to multiple natural killer subtypes".INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES 18.1(2022). |
Files in This Item: | Download All | |||||
File Name/Size | DocType | Version | Access | License |
Edit Comment
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.